Expanded CONNECT SCI Study data demonstrated unprecedented durable improvement in function, independence, and quality of life in individuals living with chronic spinal cord injury Completed a U.S. Food and Drug Administration (FDA) Type C meeting in September; FDA confirmed that multiple regulatory routes are available to support approval of NVG-291 as the first pharmacologic treatment […]

(NasdaqGM:CLSD), – Intended to Maximize Stakeholder Value Through Structured Process – – Validated SCS Microinjector(R) Delivery Platform Anchored by Commercial Product and Five Suprachoroidal Licensing Collaborations with Future Royalty Revenue Potential – – CLS-AX TKI Program Includes Phase 3-Ready Asset in Wet AMD and Path for Phase 2b/3 Trial in Diabetic Retinopathy – – IND-Ready

Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process GlobeNewswire November 24, 2025 – Intended to Maximize Stakeholder Value Through Structured Process – – Validated SCS Microinjector(R) Delivery Platform Anchored by Commercial Product and Five Suprachoroidal Licensing Collaborations with Future Royalty Revenue Potential – – CLS-AX TKI Program Includes Phase

Vancouver, British Columbia–(Newsfile Corp. – November 24, 2025) – Silver47 Exploration Corp. (TSXV: AGA) (OTCQB: AAGAF) (“Silver47” or the “Company”) is pleased to report all remaining assay results from the recently completed drill program at the Company’s wholly-owned and flagship Red Mountain Project in Alaska, USA. Key Highlights: Bonanza intercept at Dry Creek: 606 g/t silver equivalent*

NEW YORK CITY, NY / ACCESS Newswire / November 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Freeport-McMoRan Inc. ("Freeport" or "the Company") (NYSE:FCX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

Veeva to deliver next generation customer engagement with agentic AI for Roche Veeva Systems (NYSE: VEEV) today announced that Roche Pharmaceuticals has chosen to extend its partnership with Veeva Systems by adopting Veeva Vault CRM. https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo_v2.jpg “Roche and Veeva have partnered for many years,” said Veeva CEO Peter Gassner. “We are honored to extend our

Beijing, China–(Newsfile Corp. – November 24, 2025) – iHuman Inc. (NYSE: IH), a leading provider of tech-powered, intellectual development products in China, today announced that its Investor Relations Director, Justin Zhang, will present at NobleCon21 – Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton,

Markham, Ontario–(Newsfile Corp. – November 24, 2025) – Cheelcare Inc. (TSXV: CHER) (“Cheelcare” or the “Company”), a Canadian leader in assistive mobility devices, has received a “Compliant” rating from Health Canada, following a routine regulatory inspection conducted between October 22 and November 3, 2025. The inspection was conducted at Cheelcare’s new 16,000 sq. ft. manufacturing

Montreal, Quebec–(Newsfile Corp. – November 24, 2025) – Québec Innovative Materials Corp. (CSE: QIMC) (OTCQB: QIMCF) (FSE: 7FJ) (“QIMC” or the “Company”), a leader in natural hydrogen development, today announced that its pioneering exploration model has ignited a major staking rush in Nova Scotia, confirming the province as Canada’s most promising natural hydrogen jurisdiction –

Plurilock will announce Q3 2025 financial results aftermarket Wednesday November 26, 2025 Management will host a conference call on Thursday November 27, 2025, at 11am ET Vancouver, British Columbia–(Newsfile Corp. – November 24, 2025) – Plurilock Security Inc. (TSXV: PLUR) (OTCQB: PLCKF) (“Plurilock” or the “Company”), a global cybersecurity systems integrator, announces that it plans